[1]
E. Aksoy, Z. Ergenc, and H. Ergenc, “The effects of a Cilostazol, a selective phosphodiesterase III inhibitor, on liver ischemic-reperfusion injury and liver regeneration; In vitro experimental study: The effects of a Cilostazol: In vitro experimental study”, Med Sci Discov, vol. 10, no. 8, pp. 546–551, Aug. 2023.